US News

Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids

Published by
Reuters

By Michael Erman (Reuters) -Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for regulatory authorization as soon as possible to use the shot in children in that age range in the United States, Europe and elsewhere. The companies said their two-dose vaccine generated an immune response in the 5-to-11 year olds in a Phase II/III clinical trial that matched what was previously observed in 16-to-25 year olds. The safety profile was also generally comparable to the older age group, they added. “Since July, …

Read More

Facebook Comments

Check Also

Xiaomi to open car plant in Beijing with annual output of 300,000 vehicles – Beijing govt

Published by Reuters SHANGHAI (Reuters) – Chinese smartphone ...

Archives